COMMUNIQUÉS West-GlobeNewswire

Clôture de la transaction de 10 930 000 $ avec Corporation Terranueva Pharma et d’un placement privé de 2 310 000 $

17/12/2018 - 14:00

MONTRÉAL, 17 déc. 2018 (GLOBE NEWSWIRE) -- Corporation Terranueva (la « Société » ou « Terranueva ») (CSE:TEQ) est heureuse d’annoncer la finalisation d’un placement privé et de la transaction de 10 930 000 $ avec [...]

Cutera Announces Expansion of FDA Indications for enlighten™ Laser Platform

17/12/2018 - 14:00

BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]

Physeon Bolsters Management Team with New Appointments

17/12/2018 - 14:00

Experienced Executives Join Physeon Team on Heels of Commencement of US VIVA Trial SCHAFFHAUSEN, Switzerland, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical [...]

The Governance Institute Announces Governance Technology Partnership with Nasdaq

17/12/2018 - 14:00

Provides membership access to Nasdaq’s next generation and award-winning board portal and collaboration software, Nasdaq Boardvantage® LINCOLN, Neb. and NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- The Governance [...]

Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019

17/12/2018 - 14:00

Preliminary top-line data from the alcoholic steatohepatitis (ASH) collaboration with Massachusetts General Hospital shows positive effect of larazotide on ethanol-induced permeability in vitro RALEIGH, N.C., Dec. 17, [...]

PotNetwork Holdings Inc. Prepares for Surge in Interstate Commerce Following 2018 US Hemp Farm Bill

17/12/2018 - 14:00

Industry-leading Subsidiary Diamond CBD Inc., Poised to Capture Evolving Consumer Market, Prepares for Revolutionary Industry Changes FORT LAUDERDALE, Fla., Dec. 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]

Spectral Announces Results of a Face-to-Face meeting with the U.S. FDA

17/12/2018 - 14:00

TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

CLS Holdings USA Positioned for Growth in 2019

17/12/2018 - 14:00

LAS VEGAS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]

Cancer Genetics Terminates Proposed Merger with NovellusDx

17/12/2018 - 14:00

RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]

Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel

17/12/2018 - 13:50

AC5™ provides a new option for the treatment of topical wounds FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and [...]

Acarix reports first patient enrollment in new clinical investigation exploring heart failure detection

17/12/2018 - 13:45

Press release Malmö, Sweden December 17, 2018 Acarix reports first patient enrollment in new clinical investigation exploring heart failure detection Acarix has initiated a new explorative clinical study to develop a [...]

Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2019.

17/12/2018 - 13:34

Latvia, 2018-12-17 13:34 CET (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2019: Consolidated not audited interim report for the 12 months of 2018 - 18.02. [...]

FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis

17/12/2018 - 13:34

U.S. Phase 2 Study to Begin in First Quarter of 2019 NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell [...]

ProMIS Neurosciences Appoints Renowned Neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board

17/12/2018 - 13:30

TORONTO and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics [...]

TG Therapeutics, Inc. and Dana-Farber Cancer Institute Announce Publication of Clinical Data from the Phase 1/1b Trial of Umbralisib in Combination with Ibrutinib in Lancet Haematology

17/12/2018 - 13:30

NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) and Dana-Farber Cancer Institute today announced the publication of results from the multicenter Phase 1/1b trial of umbralisib (TGR-1202 [...]

Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis

17/12/2018 - 13:30

DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. [...]

Dova Pharmaceuticals Announces Management Changes

17/12/2018 - 13:30

Dr. David Zaccardelli appointed President and Chief Executive Officer Jason Hoitt appointed Chief Commercial Officer Company provides preliminary estimates of fourth quarter net product sales of $2.4 to $2.7 million for [...]

Loop Industries Appoints Sidney Horn to Board of Directors

17/12/2018 - 13:15

MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:Loop) (“Loop” or the “Company”), a leading technology innovator in sustainable plastic, announced today that its ‎Board of Directors has [...]

Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns to Accelerate the Development of New therapies and a Cure for Parkinson’s Disease

17/12/2018 - 13:10

CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]